A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults

NCT05091307 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

861

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Prevention

Interventions

BIOLOGICAL: Ad26.COV2.S
OTHER: Placebo
BIOLOGICAL: Influenza Vaccine

Sponsor

Janssen Vaccines & Prevention B.V.